Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation
- 4 July 2003
- journal article
- research article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 38 (1) , 1-16
- https://doi.org/10.1016/s0273-2300(03)00047-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Development of a Physiologically Based Pharmacokinetic Model to Describe the Disposition of Methanol in Pregnant Rats and MiceToxicology and Applied Pharmacology, 1997
- A Physiologically Based Pharmacokinetic Model for Methyl Mercury in the Pregnant Rat and FetusToxicology and Applied Pharmacology, 1995
- An in vitro method for determination of tissue partition coefficients of non‐volatile chemicals such as 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin and estradiolJournal of Applied Toxicology, 1995
- Lactational Transfer of Tetrachloroethylene in RatsRisk Analysis, 1994
- A physiologically based pharmacokinetic computer model for human pregnancyTeratology, 1994
- In vitro kinetics of styrene and styrene oxide metabolism in rat, mouse, and humanArchives of Toxicology, 1993
- A physiologically based pharmacokinetic model for nicotine and cotinine in manJournal of Pharmacokinetics and Biopharmaceutics, 1992
- Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: A multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acidToxicology and Applied Pharmacology, 1990
- A Risk Assessment Approach for Nursing Infants Exposed to Volatile Organics through the Mother's Occupational Inhalation ExposureApplied Industrial Hygiene, 1989
- Tissue and species differences in enzymes of epoxide metabolismXenobiotica, 1981